MENU
KNTE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Kinnate Biopharma (KNTE) Ownership - Who owns Kinnate Biopharma?

Kinnate Biopharma Inc is a clinical-stage precision oncology company focused on the discovery, design, and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers... Show more

Profile

Industry
N/A
Address
103 Montgomery Street
Phone
+1 858 299-4699
Employees
84
Web
https://www.kinnate.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
125.62M
P/E Ratio
N/A
Total Cash
154.03M
Projected Growth
N/A
Total Debt
3.18M
Revenue
N/A
Risk (Beta)
1.36
Dividend Yield
N/A
Total Cash/Share
3.26
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
103 Montgomery Street
Phone
+1 858 299-4699
Employees
84
Web
https://www.kinnate.com